Anaesthesia for day-stay surgery must ensure not only optimal operating conditions, but also rapid recovery after surgery. In day-stay gynaecological surgery the dangers of uterine rupture and increased bleeding in a relaxed, pregnant uterus make the avoidance of volatile anaesthetic agents desirable. For this reason we have undertaken this study of the suitability of an i.v. anaesthetic technique (supplemented with nitrous oxide by inhalation).
Etomidate, an i.v. induction agent with a short half-life (Kay, 1976a) , is theoretically well suited to day-case anaesthesia. However, its administration is associated with frequent myoclonic movements and increased muscle tone. Since the benzodiazepines and opioids have been used successfully to modify these reactions (Holdcroft et al., 1976) , such a combination was chosen after initial pilot studies.
The benzodiazepines used were either diazepam (Diazemuls) or midazolam. Diazepam has active metabolites (Baird and Hailey, 1972) and an elimination half-life of between 21 and 37 h (Thorn-Alquist, 1977) . Consequently, its use may delay recovery. Midazolam is a water soluble benzodiazepine with no active metabolites and a shorter elimination half-life (1.3-2.2 h (Finucane, Judelman and Braswell, 1982) ). It was decided to compare the quality of recovery when each of these benzodiazepines was used as part of the anaesthetic technique.
PATIENTS AND METHODS
Sixty female patients scheduled for minor gynaecological surgery as outpatients were studied. The trial was approved by the local ethics committee and all patients gave written, informed consent. All patients were ASA grade I or II, aged 15-65 yr and between 45 and 90 kg body weight. Patients with a history of hepatic, renal, haematological or metabolic disease, alcohol or drug abuse, previous psychiatric history or the regular consumption of neuroleptic drugs were excluded.
SUMMARY
No premedication was given. The patients were randomly allocated to one of two anaesthetic techniques: (i) an i.v. bolus injection of midazolam 70 ug kg" 1 and fentanyl 1.5 ug kg" 1 or (ii) an i.v. bolus injection of diazepam 150 ug kg" 1 (as an emulsion) and fentanyl 1.5 ug kg"
1 . Three minutes after the relevant injection, anaesthesia was induced with etomidate 300 ug kg"
1 . Patients then breathed 66% nitrous oxide in oxygen spontaneously via a Bain system and received intermittent bolus injections of etomidate as required to maintain anaesthesia.
To assess short term recovery the times from discontinuing the nitrous oxide to eye opening, and to giving the date of birth correctly were recorded. Recovery from general anaesthesia was assessed further at 30 min and 3 h after the withdrawal of the nitrous oxide by the Trieger test (Newman, Trieger and Miller, 1969) . This was designed as a simple objective measure of recovery from general anaesthesia. A series of equidistant dots arranged in a simple pattern are joined together as accurately as possible by the patient, using a pencil. Accuracy is measured by comparing the number of dots missed and the cumulative distance of miss in millimetres. The time taken to complete the test is also recorded. All tests are performed with the patient in the sitting position, wearing spectacles when appropriate. A baseline Trieger test was performed before induction of anaesthesia.
Before the patient was discharged from the day-stay ward, recall of events such as performance of the Trieger tests or of pain on injection of etomidate, and the incidence of nausea and vomiting were recorded. Patients were asked to volunteer comments on unpleasant aspects of the procedure and to document their subjective feeling at the time of discharge as normal, slightly unsteady or very unsteady.
Statistical analysis of the data derived from the Trieger test was by Mann-Whitney U test, that of incidence of pain on injection and its recall by Chi squared tests and recovery times by unpaired Student's t test.
RESULTS
Thirty-one patients received midazolam and 29 diazepam. They were well matched for age and weight, although more of the midazolam group underwent dilatation and curettage (D + C), thus reducing the number of terminations of pregnancy (TOP) in this group (table I) .
Patients in the diazepam group opened their eyes significantly sooner after the discontinuation of the nitrous oxide than those in the midazolam group. However, there were no significant differences in the times taken to giving the correct date of birth (table II) . Analysis of the Trieger tests revealed no significant differences between the groups at either 30 min or 3 h after anaesthesia (table III) .
There was no significant difference between the groups in the incidence of a painful reaction to the induction dose of etomidate (table IV) ; there was no visible reaction in 70% of patients. In the BRITISH JOURNAL OF ANAESTHESIA revealed complaints of nausea in 24 (40%) of the patients, the incidence being identical in the two groups. There was no significant difference between the groups in the ability to recall either the pain on injection or the performance of the 30-min Trieger test (table IV) . By 3 h after the anaesthetic, 67% of patients felt normal, 30% slightly unsteady and 3% very unsteady. All but two patients stated they would be happy to have the same anaesthetic again. All patients were discharged the same day.
DISCUSSION
Reports of the incidence of unwanted involuntary movements when etomidate was used as the sole induction agent have been as high as 90% (Zacharias et al., 1979 ), making surgery difficult or even impossible in patients similar to those studied. By administering a combination of an opioid and a benzodiazepine just before the induction of anaesthesia with etomidate, involuntary movement was eliminated in all but one patient. Zacharias and colleagues reported that premedication with pethidine reduced the incidence of movement, but this may delay recovery and the use of shorter acting agents such as fentanyl and midazolam would seem more desirable. Two studies have compared recovery after midazolam and diazepam (Magni et al., 1983; McClure, Brown and Wildsmith, 1983) . In both much greater doses were used. There was no difference between the two drugs in recovery, as judged by the Trieger test. However, the time to open eyes to command was significantly shorter in the diazepam group compared with the midazolam group. There was no apparent reason for this and there was no significant difference in the time taken to give a correct date of birth. The " second peak" effect on recovery after diazepam occurs at 6-8 h (Baird and Hailey, 1972) and would not have been detected because of the early discharge of the patients studied, but in the doses used it is very unlikely that either this, or the accumulation of the active metabolite desmethyldiazepam, would have had a significant sedative effect on the patients.
Use of the lipid emulsion formulation of diazepam has decreased its tendency to produce pain on injection (Von Dardel, Mebius and Mossberg, 1976) . However, the use of this formulation did not protect against pain on injection of etomidate, although the trend, with 21% in the diazepam group having pain on injection compared with 39% in the midazolam group, is worthy of note. Very few patients in either group recalled any pain on injection of etomidate, probably because of the amnesia produced by the benzodiazepines. The incidence of recall, assessed at discharge, of the Trieger test performed 30 min after anaesthesia was not significantly different, in contrast to the significant difference found in favour of midazolam by Magni and colleagues (1983) . The percentage of patients with no recall of the 30-min Trieger test was high: 81% after midazolam and 90% after diazepam. This is perhaps surprising, since Dundee and Wilson (1980) have reported that the amnesic effect of diazepam lasts for only a few minutes and that of midazolam for only 20 min. The prolongation of the amnesic effect may be a result of the administration of other drugs.
The incidence of nausea and vomiting is known to be high in patients such as those studied here, especially those receiving prostaglandin pessaries for TOP. This tendency may be further increased by the use of etomidate-which is associated with emergence vomiting, and the fentanyl. Zacharias and colleagues (1979) reported an incidence of nausea and vomiting after etomidate of between 35 and 45% in a similar group of gynaecological patients. The figure of 40 % reported here matches well with this.
With such a large number of patients (97%) prepared to have the same anaesthetic again and the control of the central excitatory effects of etomidate, it would appear that the anaesthetic techniques described are appropriate for day-stay surgery. However, the problems of nausea, vomiting and pain on injection remain unsolved. We feel that, if the low incidence of recall of the pain on injection was attributable to the use of the amnesic drugs, then the combination used may be unacceptable to some anaesthetists because the patients were certainly in discomfort at the time. The addition of lignocaine to the etomidate may help to eliminate the pain (Kay, 1976b) . Reports of thrombophlebitis following etomidate should be considered, but this aspect was not open to follow-up because of the early discharge of the patients, and the need for confidentiality.
